Basic and escalating immunomodulatory treatments in multiple sclerosis: Current therapeutic recommendations
Author:
Publisher
Springer Science and Business Media LLC
Subject
Neurology (clinical),Neurology
Link
http://link.springer.com/content/pdf/10.1007/s00415-008-0061-1.pdf
Reference125 articles.
1. MSTCG, et al. (2004) Escalating immunotherapy of multiple sclerosis – New aspects and practical application. J Neurol 251:1329–1339
2. MSTCG, et al. (2006) Symptomatic Treatment of Multiple Sclerosis. Eur Neurol 56:78–105
3. Goodin D, Frohman EM, Garmany GP Jr, et al. (2002) Disease modifying therapies in multiple sclerosis – Report of the therapeutics and technology assessment subcommittee of the American Academy of Neurology and the MS counsel for clinical practice guidelines. Neurology 58:169–178
4. McDonald W, Compston A, Edan G, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis. Ann Neurol 50:121–127
5. Dalton C, Dalton CM, Brex PA, et al. (2002) Application of the new McDonald criteria to patients with clinically isolated syndromes suggestive of multiple sclerosis. Ann Neurol 52:47–53
Cited by 188 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Beneficial therapeutic plasma exchange response in the treatment of severe relapses in patients with multiple sclerosis;Acta Neurologica Belgica;2024-07-24
2. Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue;Journal of Clinical Apheresis;2023-04
3. The role and therapeutic applications of exosomes in multiple sclerosis disease;Clinical and Experimental Pharmacology and Physiology;2022-09-14
4. A Pivotal Role of Nrf2 in Neurodegenerative Disorders: A New Way for Therapeutic Strategies;Pharmaceuticals;2022-05-31
5. Efficacy and safety of plasma exchange or immunoadsorption for the treatment of option neuritis in demyelinating diseases: A systematic review and meta-analysis;European Journal of Ophthalmology;2021-12-17
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3